Inquiry
Form loading...
Premium-grade bioactive compounds for professional skincare formulation
A deep-science breakdown of the phospholipid compound transforming modern acne treatment formulations worldwide.
Phosphatidylserine (PS) is a naturally occurring phospholipid found in every human cell membrane. In the context of acne treatment, pure phosphatidylserine plays a critical role in regulating cortisol-driven sebum overproduction โ one of the primary triggers of acne breakouts. When cortisol levels spike (due to stress, hormonal fluctuations, or environmental factors), sebaceous glands go into overdrive, producing excess oil that clogs pores and creates the ideal environment for Cutibacterium acnes proliferation. Clinical studies demonstrate that topical and supplemental PS can suppress HPA axis hyperactivity, directly reducing cortisol-stimulated lipid synthesis in sebocytes. Additionally, PS restores phospholipid bilayer integrity in the epidermal barrier, reducing transepidermal water loss (TEWL) and calming inflammatory cytokine cascades (IL-1ฮฑ, TNF-ฮฑ) that drive acne-associated redness and swelling.
Pure PS competitively inhibits phospholipase A2 activity in sebocytes, reducing arachidonic acid release and downstream prostaglandin synthesis. This dual action โ cortisol blunting + direct lipid pathway inhibition โ makes PS uniquely effective where conventional acne treatments often fail: stress-induced and hormonal acne.
In acne-prone skin, the stratum corneum is compromised, allowing bacterial infiltration and allergen penetration. PS replenishes the phospholipid matrix of the skin barrier, reducing TEWL by up to 40% in clinical models. Simultaneously, it modulates NF-ฮบB signaling, suppressing pro-inflammatory cytokine output and accelerating post-acne healing without the side effects associated with retinoids or benzoyl peroxide.
The commercial rise of phosphatidylserine as a premium acne treatment ingredient
The global acne treatment market, valued at over $13.5 billion in 2024, is undergoing a fundamental shift from harsh chemical treatments toward biocompatible, microbiome-friendly actives. Pure phosphatidylserine sits at the intersection of several high-growth trends: the clean beauty movement, the stress-acne awareness surge (accelerated by post-pandemic mental health discourse), and the growing demand for multifunctional cosmetic ingredients that address acne, aging, and barrier health simultaneously. Major cosmetic conglomerates including L'Orรฉal, Shiseido, and Amorepacific have filed patents incorporating PS derivatives in anti-acne formulations, signaling a mainstream commercial pivot. Meanwhile, the nutraceutical channel โ oral PS supplements for hormonal acne โ is growing at 11.2% annually, particularly in North America and South Korea.
China has emerged as the dominant global supplier of pharmaceutical-grade and cosmetic-grade phosphatidylserine, accounting for over 70% of world production. Key manufacturing hubs in Shaanxi, Shandong, and Zhejiang provinces leverage advanced enzymatic phospholipase D transphosphatidylation processes to produce soy-derived and sunflower-derived PS with purities exceeding 98%. The shift from soy to sunflower-derived PS is accelerating due to non-GMO demand and allergen-free certification requirements in the EU and North American markets. Bulk pricing for 20% PS powder ranges from $45โ$80/kg, while high-purity โฅ98% PS commands $180โ$320/kg in specialty cosmetic markets.
Pure phosphatidylserine for acne treatment applications must navigate a complex regulatory environment. In the EU, PS is listed under Cosmetics Regulation (EC) No 1223/2009 as a permissible cosmetic ingredient (INCI: Phosphatidylserine). The FDA classifies dietary PS as GRAS (Generally Recognized as Safe) for oral supplements. ISO 22716 GMP certification, Cosmos/Ecocert organic certification, and HALAL/KOSHER compliance are increasingly mandatory for export markets. Leading Chinese manufacturers are investing heavily in these certifications to access premium European and North American retail channels, where PS-formulated acne products command 3โ5ร price premiums over conventional treatments.
How pure phosphatidylserine is being deployed across diverse acne treatment formats and skin types
The fastest-growing application segment. Formulators are incorporating 1โ4% pure PS (as a 20% standardized powder) into water-based serums targeting adult women aged 25โ40 experiencing stress-triggered breakouts. Unlike salicylic acid or niacinamide which address surface symptoms, PS-based serums target the root cortisol-sebum axis. Clinical trials by Korean cosmetic research institutes show 34% reduction in sebum output and 28% reduction in inflammatory lesion count after 8 weeks of twice-daily PS serum application. These products are positioned at the premium tier ($45โ$120 retail) and are particularly successful in direct-to-consumer e-commerce channels in the US, UK, and South Korea.
Nutraceutical brands are launching PS softgels (100โ300mg/day) specifically marketed for hormonal acne, particularly targeting PCOS-associated breakouts. PS supplementation has been shown to reduce salivary cortisol by 30% in stressed individuals, indirectly suppressing androgen-driven sebum production. The oral supplement format is growing rapidly in markets where topical actives face stricter cosmetic claim regulations, allowing brands to make more direct efficacy claims under supplement frameworks.
Dermatology clinics and medical spa brands are incorporating PS into post-procedure recovery protocols for acne patients undergoing chemical peels, laser treatments, or microneedling. PS's barrier-rebuilding and anti-inflammatory properties accelerate healing, reduce post-inflammatory erythema (PIE), and prevent secondary breakouts triggered by procedure-induced stress. This positions PS as a complementary professional-use ingredient alongside established actives like azelaic acid and tranexamic acid.
Sheet masks and wash-off clay masks incorporating PS at 0.5โ2% are gaining traction in the clean beauty segment. PS enhances the delivery of co-actives (zinc PCA, green tea EGCG, niacinamide) into sebaceous follicles via its natural affinity for phospholipid membranes, acting as a bio-enhancer that amplifies the efficacy of the entire formulation.
Emerging research reveals PS modulates the skin microbiome by selectively supporting commensal bacteria (Staphylococcus epidermidis) while creating an inhospitable environment for C. acnes. This prebiotic-like action is driving interest from next-generation microbiome skincare brands developing PS-based acne treatments without traditional antimicrobials.
Advanced formulators are pairing PS with ceramides (barrier synergy), retinaldehyde (cell turnover + PS anti-irritation buffering), and adaptogens like ashwagandha extract (dual cortisol suppression). These synergistic combinations are commanding premium positioning in prestige skincare and are the subject of multiple pending EU and US cosmetic patents filed in 2023โ2025.
Your trusted source for pure phosphatidylserine and premium cosmetic bioactives
Shaanxi Qiyuan Kangjian Biotechnology Co., Ltd. is located in Xi'an, Shaanxi Province, China, and specializes in supplying peptides, food additives, nutritional supplements, traditional Chinese medicine (TCM) extracts, plant extracts, and natural active ingredients โ including pharmaceutical and cosmetic-grade pure phosphatidylserine for acne treatment applications.
Established in 2022, the company operates two major production bases in Weinan and Xianyang, with GMP-compliant manufacturing infrastructure, advanced analytical capabilities, and a global distribution network serving clients in the pharmaceutical, health product, and cosmetics industries across 36+ countries.
Qiyuan Kangjian Biotech Co., Ltd.
Our team members are familiar with the trade policies and compliance requirements of various countries, always prioritizing customer needs, strictly controlling quality, and responding efficiently. From order negotiation to after-sales follow-up, dedicated personnel handle the entire process, using professionalism and integrity to build bridges for cross-border cooperation and help partners explore global business opportunities.
Our R&D specialists bring deep expertise in phospholipid chemistry, enabling us to offer custom PS specifications โ purity levels, particle sizes, and extraction methods โ tailored precisely to your acne treatment formulation requirements.
Contact Us โGMP-compliant production infrastructure ensuring the highest purity phosphatidylserine for acne treatment
The company has two major production bases in Weinan and Xianyang. Weinan Shenhekang Bioengineering Co., Ltd., established in 2022, boasts a 6,000-square-meter GMP-compliant production workshop equipped with multi-functional plant extraction equipment for extraction, separation, concentration, and drying.
Global reach, local expertise โ delivering pure phosphatidylserine for acne treatment worldwide
Explore our full range of high-purity bioactive ingredients for professional acne treatment formulation